Lewis Tanya has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 32162 shares of DiaMedica Therapeutics Inc. ($DMAC) on June 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 1, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Lewis Tanya | Director | A | Stock Option (right to buy) | 32162 | $0.00 | 32,162.0000 | 42,855,660 | 9999.99% | 0.08% |
| June 1, 2024 | DiaMedica Therapeutics Inc. | $DMAC | Lewis Tanya | Director | A | Stock Option (right to buy) | 28472 | $0.00 | 28,472.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Lewis Tanya | Director | A | Stock Option (right to buy) | 7493 | $0.00 | 7,493.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Lewis Tanya | Director | A | Stock option (right to buy) | 26443 | $0.00 | 26,443.0000 | 0 | 9999.99% | 0.00% |